Matrixx Initiatives, Inc. (NASDAQ:MTXX)

CAPS Rating: 5 out of 5

The Company develops, produces, markets and sells innovative, over-the-counter healthcare products.

Recs

0
Player Avatar Comatosis2007 (< 20) Submitted: 10/4/2006 5:16:59 PM : Outperform Start Price: $20.06 MTXX Score: -60.35

Cold season is around the corner and this homeopathic cold remedy provider should benefit from increasing brand awarenees and purchases of its Zicam branded products.

Featured Broker Partners


Advertisement